Cryobiopsy with radial-endobronchial ultrasound (Cryo-Radial) has comparable diagnostic yield with higher safety in comparison to computed tomography-guided transthoracic biopsy for peripheral pulmonary lesions : An exploratory randomised study
© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians..
BACKGROUND: Computed tomography-guided transthoracic biopsy (CT-TTB) is the 'gold standard' biopsy for lung nodules. Radial-endobronchial ultrasound (R-EBUS) bronchoscopy is another recommended biopsy but carries a lower diagnostic yield. Addition of cryobiopsy with R-EBUS (Cryo-Radial) has shown promising results. There are no studies comparing CT-TTB with Cryo-Radial biopsy.
AIM: The co-primary aims were the diagnostic yeild and safety. The secondary aim: ability to test epidermal growth factor receptor (EGFR).
METHODS: A randomised controlled, multicentre exploratory study was conducted at three tertiary hospitals. Patients with nodules >1 cm on CT of the chest were randomised to CT-TTB or Cryo-Radial. With Cryo-Radial, patients had 1-3 cryo-biopsies in addition to at least one R-EBUS biopsy through the 2.6 mm guide sheath.
RESULTS: Forty-eight patients were randomised: 22 to CT-TTB and 26 to Cryo-Radial. Sixteen in the CT-TTB and 20 in the Cryo-Radial received the allocated biopsy. The diagnostic yield was CT-TTB 93.8% (15/16) versus Cryo-Radial 85% (17/20) P = 0.61 and the odds ratio was 0.37. For 5/13 (38%), a diagnosis was solely made on cryobiopsy. Eleven (78%) of 14 in CT-TTB versus 7/10 (70%) Cryo-Radial were suitable for EGFR testing P = 0.66, with odds ratio 0.63. Pneumothorax occurrence was 44% (7/16) in CT-TTB versus 4.2% (1/24) in Cryo-Radial. Two (12.5%) of 16 CT-TTB required chest drain insertion.
CONCLUSION: Cryo-Radial is comparable in diagnostic yield and ability to perform EGFR testing with a significantly lower risk of pneumothorax, compared with CT-TTB. Cryo-Radial has the additional advantage of mediastinal staging during the same procedure with Linear-EBUS and is a promising first-line tool in the diagnostic method of lung cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Internal medicine journal - 53(2023), 8 vom: 01. Aug., Seite 1390-1399 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Herath, Samantha [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bleeding |
---|
Anmerkungen: |
Date Completed 22.08.2023 Date Revised 29.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/imj.15833 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM341969419 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM341969419 | ||
003 | DE-627 | ||
005 | 20231226013008.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/imj.15833 |2 doi | |
028 | 5 | 2 | |a pubmed24n1139.xml |
035 | |a (DE-627)NLM341969419 | ||
035 | |a (NLM)35675149 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Herath, Samantha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cryobiopsy with radial-endobronchial ultrasound (Cryo-Radial) has comparable diagnostic yield with higher safety in comparison to computed tomography-guided transthoracic biopsy for peripheral pulmonary lesions |b An exploratory randomised study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.08.2023 | ||
500 | |a Date Revised 29.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. | ||
520 | |a BACKGROUND: Computed tomography-guided transthoracic biopsy (CT-TTB) is the 'gold standard' biopsy for lung nodules. Radial-endobronchial ultrasound (R-EBUS) bronchoscopy is another recommended biopsy but carries a lower diagnostic yield. Addition of cryobiopsy with R-EBUS (Cryo-Radial) has shown promising results. There are no studies comparing CT-TTB with Cryo-Radial biopsy | ||
520 | |a AIM: The co-primary aims were the diagnostic yeild and safety. The secondary aim: ability to test epidermal growth factor receptor (EGFR) | ||
520 | |a METHODS: A randomised controlled, multicentre exploratory study was conducted at three tertiary hospitals. Patients with nodules >1 cm on CT of the chest were randomised to CT-TTB or Cryo-Radial. With Cryo-Radial, patients had 1-3 cryo-biopsies in addition to at least one R-EBUS biopsy through the 2.6 mm guide sheath | ||
520 | |a RESULTS: Forty-eight patients were randomised: 22 to CT-TTB and 26 to Cryo-Radial. Sixteen in the CT-TTB and 20 in the Cryo-Radial received the allocated biopsy. The diagnostic yield was CT-TTB 93.8% (15/16) versus Cryo-Radial 85% (17/20) P = 0.61 and the odds ratio was 0.37. For 5/13 (38%), a diagnosis was solely made on cryobiopsy. Eleven (78%) of 14 in CT-TTB versus 7/10 (70%) Cryo-Radial were suitable for EGFR testing P = 0.66, with odds ratio 0.63. Pneumothorax occurrence was 44% (7/16) in CT-TTB versus 4.2% (1/24) in Cryo-Radial. Two (12.5%) of 16 CT-TTB required chest drain insertion | ||
520 | |a CONCLUSION: Cryo-Radial is comparable in diagnostic yield and ability to perform EGFR testing with a significantly lower risk of pneumothorax, compared with CT-TTB. Cryo-Radial has the additional advantage of mediastinal staging during the same procedure with Linear-EBUS and is a promising first-line tool in the diagnostic method of lung cancer | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a CT-guided biopsy | |
650 | 4 | |a EGFR | |
650 | 4 | |a bleeding | |
650 | 4 | |a cryo-biopsy | |
650 | 4 | |a diagnostic yield | |
650 | 4 | |a radial EBUS | |
700 | 1 | |a Wong, Conroy |e verfasserin |4 aut | |
700 | 1 | |a Dawkins, Paul |e verfasserin |4 aut | |
700 | 1 | |a Veale, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Yap, Elaine |e verfasserin |4 aut | |
700 | 1 | |a Williamson, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Low, Irene |e verfasserin |4 aut | |
700 | 1 | |a Mahajan, Hema |e verfasserin |4 aut | |
700 | 1 | |a Prvan, Tania |e verfasserin |4 aut | |
700 | 1 | |a Barnard, Stuart |e verfasserin |4 aut | |
700 | 1 | |a Hawkins, Stewart |e verfasserin |4 aut | |
700 | 1 | |a Cookson, Dan |e verfasserin |4 aut | |
700 | 1 | |a Singh, Tushar |e verfasserin |4 aut | |
700 | 1 | |a Ing, Alvin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Internal medicine journal |d 2001 |g 53(2023), 8 vom: 01. Aug., Seite 1390-1399 |w (DE-627)NLM113582811 |x 1445-5994 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2023 |g number:8 |g day:01 |g month:08 |g pages:1390-1399 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/imj.15833 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 53 |j 2023 |e 8 |b 01 |c 08 |h 1390-1399 |